Etamicastat hydrochloride (BIA 5-453 hydrochloride) is a potent and reversible dopamine-β-hydroxylase (DBH) inhibitor with an IC50 value of 107 nM. Etamicastat can be used in the research of cardiovascular diseases.
IC50&Target
IC50: 107 nM (DBH)
体外研究
Etamicastat blocks the hERG current amplitude with an IC50 value of 44 μg/mL (141 μM).
体内研究
Etamicastat (100 mg/kg; administered intraperitoneally) leads to a significant reduction of noradrenaline levels in heart with concomitant increasing in dopamine levels.
Etamicastat (50 mg/kg; a single oral administration) exhibits moderate oral bioavailability (64%), Cmax (4.9 nM), and terminal elimination half-lives (T1/2=3.7 h) in male Wistar rats.
Animal Model:
NMRi mice
Dosage:
100 mg/kg
Administration:
Administered intraperitoneally
Result:
Led to a significant reduction of noradrenaline levels (36% control) in heart with concomitant increasing in dopamine levels (850% of control).
Animal Model:
Male Wistar rats
Dosage:
50 mg/kg (Pharmacokinetic Analysis)
Administration:
Orally administered with at a dose volume of 10 mL/kg
Result:
Oral bioavailability (64%), Cmax (4.9 nM), and (T1/2=3.7 h).
分子式
C14H16ClF2N3Os
分子量
347.81
CAS号
677773-32-9
中文名称
依他米司特盐酸盐
运输条件
Room temperature in continental US; may vary elsewhere.